{
    "nctId": "NCT05933876",
    "briefTitle": "The Impact of Radiotherapy on Oligometastatic Cancer",
    "officialTitle": "Stereotactic ABlative Radiotherapy (SABR) in Oligometastatic Cancer (OC): a Radiomics, Multi-omics, and Machine Learning Approach to Clinical Decision-making. The OC-SABR Multicentric Project",
    "overallStatus": "RECRUITING",
    "conditions": "Metastasis, Metastatic Breast Cancer, Metastatic Prostate Cancer, Metastatic Colorectal Cancer, Metastatic Lung Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 2000,
    "primaryOutcomeMeasure": "Radiological rate",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Histologic confirmation of primary tumor: breast, prostate, lung, colorectal.\n* 18 years old or older.\n* Up to five metastases located in the bone, lung, node, liver or brain.\n* Eastern Cooperative Oncology Group (ECOG) Performance Status Scale 0 or 1.\n\nExclusion Criteria:\n\n* Non-melanoma skin cancer.\n* Previous radiotherapy in the same anatomic location.\n* Presence of vascular collagen disease.\n* Pregnancy or lactation at the time of inclusion.",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}